
Loading, please wait...

Loading, please wait...

This systematic review and network meta-analysis included 52 double-blind randomized controlled trials with 7,316 patients (43 trials in adults and 9 in children and adolescents). They compared clomipramine, six SSRIs, venlafaxine and placebo over 8 to 16 weeks for the acute treatment of obsessive-compulsive disorder. Outcomes were change on the Yale-Brown Obsessive Compulsive Scale and dropout due to adverse events. In adults, clomipramine had the largest effect versus placebo (effect size 0.71), with SSRIs ranging from 0.37 (fluoxetine) to 0.63 (fluvoxamine), while venlafaxine did not differ from placebo. In youth, the effect of clomipramine versus placebo was 1.19, based on a single trial of 31 patients. SSRI response increased from 20 to 40 mg fluoxetine-equivalent with no further gain at 60 mg. Adults on clomipramine were nearly five times more likely than placebo to discontinue because of adverse effects, and escitalopram was the only drug that did not increase adverse-effect dropouts. The authors concluded that clomipramine showed the largest estimated efficacy for OCD but lower tolerability than SSRIs, with its superiority over individual SSRIs more pronounced in children and adolescents.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This systematic review and network meta-analysis included 52 double-blind randomized controlled trials with 7,316 patients (43 trials in adults and 9 in children and adolescents). They compared clomipramine, six SSRIs, venlafaxine and placebo over 8 to 16 weeks for the acute treatment of obsessive-compulsive disorder. Outcomes were change on the Yale-Brown Obsessive Compulsive Scale and dropout due to adverse events. In adults, clomipramine had the largest effect versus placebo (effect size 0.71), with SSRIs ranging from 0.37 (fluoxetine) to 0.63 (fluvoxamine), while venlafaxine did not differ from placebo. In youth, the effect of clomipramine versus placebo was 1.19, based on a single trial of 31 patients. SSRI response increased from 20 to 40 mg fluoxetine-equivalent with no further gain at 60 mg. Adults on clomipramine were nearly five times more likely than placebo to discontinue because of adverse effects, and escitalopram was the only drug that did not increase adverse-effect dropouts. The authors concluded that clomipramine showed the largest estimated efficacy for OCD but lower tolerability than SSRIs, with its superiority over individual SSRIs more pronounced in children and adolescents.
Today

India faces a massive diabetes burden with over 89 million adults affected. Managing blood sugar in isolation fails to prevent severe cardiorenal complications. Clinicians must adopt an integrated metabolic ecosystem that prioritizes early detection, multifactorial risk assessment, and personalized therapies.
6 days back

Maternal anaemia contributes to nearly half of pregnancy-related fatalities across India. To prevent complications, Uttar Pradesh has added single-dose parenteral iron to its essential medicines list. This clinical transition aims to restore haemoglobin rapidly and protect high-risk mothers across rural facilities.
last month

India's food safety authority FSSAI has issued show-cause notices to Gemini Edibles, BigBasket, and Flipkart for unpermitted cardiovascular claims regarding Freedom Rice Bran Oil. This regulatory move highlights the strict enforcement of advertising standards and the clinical necessity of evidence-based lipid care.
last month

The state government is deploying helicopter emergency medical services across the Mumbai-Pune Expressway, Samruddhi Mahamarg, and Mumbai-Goa Highway. This initiative establishes unified standard operating procedures to enable rapid triage, advanced prehospital resuscitation, and seamless trauma care transfers.
last month

Atherosclerotic cardiovascular disease guidelines often rely on European-derived lipoprotein(a) cutoffs. However, baseline Lp(a) levels vary widely across ancestries, including South Asians and Africans. Clinicians must interpret Lp(a) values within overall absolute cardiovascular risk.
last month